Discussions Populaires Dans la Communauté Produits biopharmaceutiques

The main challenge of AIT ( Allergen Immunotherapy ) is the prevention of allergy disease progression ? Are you Agree ? Explain ?‎

Réponses:

1

Adeptes:

1

Vues:

177

Vote Count:

0

How would you validate the cleaning process after producing Anthrax in a fermenter if you plan to follow it with a non spore forming product?‎

This scenario is where only one batch is produced in two to three years and building a separate facility as per GMP guidelines is not financially viable.‎

Réponses:

2

Adeptes:

2

Vues:

9

Vote Count:

0

 

La répondre a été ajoutée par  Muntakhib khatib , Executive , Biocon
Depuis 9 années

Yes i agree with the concept. Because when harmless antigen is administered into human body, antibody produces against that particular antigenic structure. In the process ... Voir Plus

 

La répondre a été ajoutée par  Shawal Hameed
Depuis 6 années

First of all we need to define validation for cleaning process. that is nothing but ask yourself Are we performing right clenaing process? Now we need to identify the obj ... Voir Plus

 

La répondre a été ajoutée par  Mohamed Elhibishy, QA Manager, Pioneer Co. For Pharmaceuitical Industry
Depuis 6 années

This really hard Question , for my self , I did not work in biotechnology field but if you need brainstorming , We need to agree at first that m.o not like chemicals , no ... Voir Plus